Security record · archived quarter
ANGO
AngioDynamics, Inc. · Healthcare · Medical - Instruments & Supplies
2Tracked holders
-1Δ holders
43.99KShares held
$609,074Reported value
+0New positions
−1Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 43.99K | $609,074 | n/a | −1 |
| Q2 2026 | 71 | +3 | 20.21M | $262.94M | +7 | −5 |
| Q1 2026 | 71 | -1 | 21.06M | $239.47M | +4 | −5 |
| Q4 2025 | 72 | 0 | 22.40M | $287.62M | +1 | −1 |
| Q3 2025 | 18 | 0 | 15.02M | $167.73M | n/a | n/a |
| Q2 2025 | 15 | -1 | 13.76M | $136.51M | n/a | −1 |
| Q1 2025 | 13 | +2 | 6.65M | $62.49M | +2 | n/a |
| Q4 2024 | 11 | 0 | 7.29M | $66.82M | n/a | n/a |
| Q3 2024 | 10 | 0 | 5.47M | $42.55M | n/a | n/a |
| Q2 2024 | 10 | n/a | 5.27M | $31.86M | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 27.73K | -50.0% | $426,441 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 16.26K | +18.4% | $182,633 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| TD Waterhouse Canada Inc. | $9,818 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 145 holders, 38.52M shares, $430.26M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API